Cargando…
Rapid Diagnosis of Tuberculosis with the Xpert MTB/RIF Assay in High Burden Countries: A Cost-Effectiveness Analysis
BACKGROUND: Xpert MTB/RIF (Xpert) is a promising new rapid diagnostic technology for tuberculosis (TB) that has characteristics that suggest large-scale roll-out. However, because the test is expensive, there are concerns among TB program managers and policy makers regarding its affordability for lo...
Autores principales: | Vassall, Anna, van Kampen, Sanne, Sohn, Hojoon, Michael, Joy S., John, K. R., den Boon, Saskia, Davis, J. Lucian, Whitelaw, Andrew, Nicol, Mark P., Gler, Maria Tarcela, Khaliqov, Anar, Zamudio, Carlos, Perkins, Mark D., Boehme, Catharina C., Cobelens, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210757/ https://www.ncbi.nlm.nih.gov/pubmed/22087078 http://dx.doi.org/10.1371/journal.pmed.1001120 |
Ejemplares similares
-
Using Xpert MTB/RIF
por: Nicol, Mark P., et al.
Publicado: (2013) -
Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study
por: Boehme, Catharina C, et al.
Publicado: (2011) -
Xpert® Mtb/Rif assay for pulmonary tuberculosis and rifampicin resistance in adults
por: Steingart, Karen R, et al.
Publicado: (2013) -
Optimal Triage Test Characteristics to Improve the Cost-Effectiveness of the Xpert MTB/RIF Assay for TB Diagnosis: A Decision Analysis
por: van’t Hoog, Anna H., et al.
Publicado: (2013) -
Need to confirm isoniazid susceptibility in Xpert MTB/RIF rifampin susceptible cases
por: Vadwai, Viral, et al.
Publicado: (2012)